Phillip Smith, DO
Pain Medicine · Rancho Mirage, CANPI 1386879625
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 36 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Abbott accounts for 78.4% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2019 at $558 and has fallen 67.5% since, to $182 in 2025. That places this record below the midpoint for pain medicine clinicians in CA, where the typical reported total is $1,829.
Across 36 payments — averaging $57.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$2K
- AbbVie$224
- Vital Orthopedics LLC$101
- Empire Medical, Inc$98
- Stryker$27
What the payments were for
- Food & beverage$2,084100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Proclaim Family of SCS IPGs$711
- Octrode SCS Leads$154
- OCTRODE$150
- BOTOX$118
How this compares
$2,084 in reported general payments places this provider in the 50th percentile of 840 pain medicine providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 316 | $3,063 |
| Cyclobenzaprine Hcl | 34 | $976 |
| Pregabalin | 30 | $931 |
| Duloxetine Hcl | 14 | $433 |
| Baclofen | 31 | $354 |
| Tramadol Hcl | 81 | $304 |
| Meloxicam | 46 | $165 |
| Diclofenac Sodium | 12 | $165 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 17 | $162 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 11 | $115 |
| Ibuprofen | 11 | $72 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Rancho Mirage
- Jason PopeSanta Rosa$2.1M
- Ramana NaiduLarkspur$1.4M
- Foead GeulaStudio City$1.3M
- Krishnan ChakravarthyTemecula$1.3M
- Kasra AmirdelfanWalnut Creek$783K
- Eric GrigsbyNapa$499K
- Jacqueline WeisbeinNapa$494K
- Gerald SacksSanta Monica$389K
- Samir ShethRoseville$356K
- Einar OttestadStanford$352K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.